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Clinic, Universitaf de Barcelona, Barcelona, Spain 
The objective of this study was the analysis of five sets of reference equations for forced spirometry (Crap0 et al., 
ECSC, Knudson et al., Paoletti et al. and Rota et al.) using measurements of FVC and FEV, obtained in the 
European Community Respiratory Health Survey (ECRHS) in Spain. 
Standardized forced spirometry was measured in 998 non-asthmatic subjects (2@44 years), randomly selected 
from the general population, participating in the ECRHS in four different Spanish cities. Observed minus predicted 
values for both FVC and FEV, were examined for each set of predicted equations. 
Observed FVC (4448 f 980 ml) and FEV, (3715 f 813 ml) showed a good agreement with values predicted by 
Rota et al. (99% and lOl%, respectively). The mean observed minus predicted difference (residual) for FVC and 
FEV, were - 34 f 527 ml and 30 * 455 ml, respectively. The regression line between observed and predicted values 
was not different from the identity line for both FVC and FEV,. 
These results indicate that reference values obtained by Rota et al. are useful for the assessment of the ventilatory 
capacity in the general population of Spain. In addition, the study indicates that discrepancies among the reference 
equations from different authors compared in the present study are unlikely to be due to ethnic differences within 
European origin populations. 
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Introduction 
The reference equations for forced spirometry of non- 
smoking Caucasians selected by the American Thoracic 
Society (ATS) in 1991 (1) showed striking differences 
among studies (2-10) in predicted forced vital capacity 
(FVC) (up to 640 ml) and in predicted forced expiratory 
volume during the first second (FEV,) (up to 310 ml). The 
magnitude of these differences gives rise to potential con- 
cerns for the clinical assessment of ventilatory capacity. 
One of these sets of equations was derived by our group in 
the early 1980s from a population of 870 healthy non- 
smoker volunteers (443 men and 427 women) 20-70 years 
of age living at sea level in Barcelona, Spain (8). Predicted 
FVC and FEV, from Rota et ul.‘s study are placed in the 
upper portion of the range of predicted values for a given 
gender, age and height derived from the reference equations 
(2-10) selected in the ATS report. 
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The specific aim of the present study was to validate this 
set of reference values (8) against standardized measure- 
ments (11,12) of forced spirometry carried out in 998 
non-asthmatic subjects (524 men and 474 women) partici- 
pating in the European Community Respiratory Health 
Survey (ECRHS) in Spain (13). A second main goal of the 
study was to compare the spirometric measurements from 
the ECRHS with other sets of equations (4,6,8,9) derived 
from populations of European origin and specifically with 
the European Community Summary equations (ECSC 
equations) (5) recommended by the European Respiratory 
Society (ERS) (11). 
Materials and Methods 
THE SUBJECTS OF THE ECRHS 
The protocol for the ECRHS has been described elsewhere 
(13,14). Briefly, participating centres selected an area 
defined by pre-existing administrative boundaries, with a 
population of at least 150 000 individuals. Where possible 
an up-to-date sampling frame was used to select randomly 
at least 1500 men and 1500 women, aged 20-44 years. In 
stage I, subjects were sent a questionnaire enquiring about 
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respiratory symptoms and attacks of asthma over the last 
12 months, current use of asthma medication and nasal 
allergies including hay fever. A random sample of subjects 
were selected to take part of stage II. Those who had 
already responded to stage I were invited to answer a more 
detailed administered questionnaire and to take part in 
blood tests, skin tests, assessment of lung function by 
spirometry and airway challenge with methacholine. The 
questionnaire collected information on health status, 
current smoking and smoking history. Subjects who 
reported asthma-related symptoms were excluded. In the 
ECRHS, a subject with asthma-related symptoms was 
defined as one who reported any of the following three 
conditions: (a) being woken up by an attack of shortness 
of breath at any time over the last 12 months, (b) having 
an attack of asthma during the last 12 months and (c) 
currently taking any medicine for asthma (including 
inhalers, aerosols or tablets). 
In each of the Spanish areas participating in the ECRHS, 
approximately 3000 subjects were randomly selected from 
the general population of 2044 years of age, completing a 
final sample of 17 200 subjects. Of these, 16 884 subjects 
(98.2%) were eligible for the study. The remaining 1.8% 
were excluded because of errors in age, mental disability or 
error in the city census. In stage II, 3310 subjects were 
randomly selected, before the beginning of the study, from 
the initial population sample. The stage I questionnaire 
enquiring about respiratory symptoms was completed by 
2761 (83.4%) subjects. Of these, 223 (8.3%) were sympto- 
matic, as previously defined, whereas the remaining 2538 
(91.9%) did not show asthma-related symptoms. Response 
to the stage II questionnaire and the forced spirometry was 
obtained in 141 (63.2%) of the symptomatic subjects and in 
1388 (54.7%) of those without symptoms of asthma. The 
proportion of respondents to stages I and II as well as the 
proportion of subjects with and without asthma-related 
symptoms in the random subsample were similar to those 
for the rest of the sample. The final eligible population for 
the present study included the 1388 asymptomatic subjects 
from the random subsample who completed the detailed 
questionnaire and the forced spirometry. 
The distribution of eligible subjects according to the 
Spanish centres of the ECRHS was as follows: (a) centre A, 
194 subjects (Hospital Clinic, Barcelona, northeast of 
Spain); (b) centre B, 367 subjects (Hospital de Galdakao, 
Galdakao, north); (c) centre C, 227 subjects (Instituto 
National de Silicosis, Oviedo, northwest); (d) centre D, 210 
subjects (Hospital General Manuel Lois, Huelva, south- 
west); (e) centre E, 390 subjects (Hospital General de 
Albacete, Albacete, southeast). Centre E was not included 
in the present study because it did not fulfil the quality 
assurance programme. Consequently, the final calculations 
were carried out within 998 subjects (524 men and 474 
women) from centres A-D. 
SPIROMETRIC MEASUREMENTS AND QUALITY 
CONTROL 
Forced spirometry was carried out with subjects in the 
sitting position and using nose-clips. Measurements were 
done using a 10 1 water-sealed spirometer (Biomedin, 
Padova, Italy). The equipment has a resolution of 5 ml and 
shows linearity within a flow range of O-15 1 s - I. The 
frequency response is flat within 10% up to 15 Hz and the 
dynamic resistance is lower than 0.1 kPa l- ’ s (at 12 1 s - ’ 
flow). Performance of the manoeuvres, data collection, 
algorithms of calculation and quality controls met both the 
1983 European Community for Steel and Coal (ECSC) (5) 
and the 1987 ATS (12) recommendations. Details of the 
measurements have been reported elsewhere (13,14). 
Forced vital capacity and FEV, were calculated and 
expressed at BTPS conditions. Both ambient temperature 
and temperature inside the spirometer were taken into 
account for ATPS to BTPS corrections. All the technicians 
involved in the study received identical training by the two 
members of the team co-ordinating the quality control 
programme (J.C. and F.B.) in Spain. At the commencement 
of the ECRHS, a quality control visit to each laboratory 
was carried out by either the personnel of the Coordinating 
Centre (London) or both J.C. and F.B. to examine all the 
procedures involved in the protocol. They specifically 
checked the volume signal of the equipment using a 3 1 
calibrated syringe (Warren Collins, Chatham, MA, U.S.A.) 
and examined the equipment for leaks. During the study, 
verification of the volume signal of the equipment using 
calibrated syringes (2 or 3 1) was performed on a daily basis, 
whereas checks for both leaks and timing were carried out 
monthly. The same technicians in each laboratory per- 
formed the tests throughout the study. In centre B and 
centre C (Galdakao and Oviedo, respectively) technicians 
experienced in lung function testing participated in this 
study while in centre A and centre D (Barcelona and 
Huelva, respectively) technical personnel without previous 
experience in lung function testing were specifically trained 
for the study. 
REFERENCE EQUATIONS 
The characteristics of the five sets of reference equations 
examined in this study (Table 1) have been described in 
detail elsewhere (46,8,9). The ECSC equations were 
derived from data from different studies carried out 
before the 1980s using different methods and from differing 
populations, as reported in (5). The remaining four studies 
were derived following modern standards (5,15) and they 
were reported throughout the 1980s. Prediction equations 
for FEV, given by Rota et al. (8) in the present study 
were corrected with back-extrapolation following the 
calculations reported in (8). 
DATA ANALYSIS 
Observed minus predicted differences (residuals) for FVC 
and FEV, were calculated separately for each of the four 
centres participating in the study. The paired Student’s t 
test was used to compare observed versus predicted spiro- 
metric (FVC and FEV,) values. The whole group of 998 
non-asthmatic subjects from the ECRHS was used to 
examine the sets of reference equations reported by differ- 
ent authors. Moreover, values predicted by Rota et al. were 
TABLE 1. Prediction equations examined in the present study 
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Men Women 
Equation r RSD Equation r RSD 
FVC 
ECSC (5) 0.05768 - 0.026A - 4.340 NA 0.61 0.04438 - 0.0260A - 0.2890 NA 0.43 
Knudson et al. (6) 0.08448 - 0.02984 - 8.782 0.85 0.64 0.04448-0.0169A - 3.195 0.70 0.48 
Paoletti et al. (9) 0.07248 - 0.02734 - 6.382 0.69 0.58 0.0412H - 0.0154A - 2.329 0.62 0.39 
Crap0 et al. (4) 0.0600H - 0.0214A - 4.650 0.73 0.64 O.O491H- 0.0216A - 3.590 0.86 0.39 
Rota et al. (8) 0.06788 - 0.0147A - 6.055 0.72 0.53 0.04548 - 0.0211 A - 2.825 0.75 0.40 
FEV, 
ECSC (5) 0.0430H - 0.0290A - 2.490 NA 0.51 0.03958 - 0.025A - 2.600 NA 0.38 
Knudson et al. (6) 0.06658- 0.02924 - 6.515 0.86 0.52 0.06658 - 0.02924 - 6.5 15 0.86 0.52 
Paoletti et al. (9) 0.04948 - 0.02754 - 3.576 0.59 0.48 0.02438 - 0.0196A - 0.282 0.69 0.29 
Crap0 et al. (4) 0.0414H - 0.02444 - 2.190 0.80 0.49 0.03428 - 0.02554 - 1.578 0.89 0.33 
Rota* O.O514H- 0.0216A - 3.955 0.75 0.45 0.03268- 0.02534 - 1.286 0.82 0.32 
H, height in cm; A, age in years; r, correlation coefficient; RSD, residual standard deviation; *FEV, calculated with 
back-extrapolation as described in detail in (8). 
examined using the following subgroups of subjects: (a) 
current smokers (n = 530); (b) non-smokers plus ex-smokers 
(n=468); (c) lifetime non-smokers (n=333) and (d) those 
subjects from the ECRHS sample who fulfilled the criteria 
used to define a reference subject in Rota et ~1,‘s reference 
equations (n=248) (8,16). Validation of the reference 
values given by Rota et al. was assessed by regressing the 
observed spirometric values from the ECRHS against the 
corresponding predicted values (Table 1). The regression 
line between observed and predicted values should not 
be different from the line of identity. Except for the 
standard errors of the regression coefficients, results are 
expressed as mean f standard deviation. The lower limit of 
reference (LLR) was calculated as follows: predicted 
value - 1.645 x RSD (where RSD is the residual standard 
deviation). For comparisons among authors, the LLR was 
calculated using the RSD of the corresponding equation. A 
value of PcO.05 was accepted as statistically significant. 
Results 
The characteristics of the ECRHS’s subjects, smoking 
habits and differences between observed and the 
corresponding predicted values calculated using the refer- 
ence equations provided by Rota et al. for each of the 
centres participating in the present study are presented in 
Table 2. The magnitude of the difference between observed 
and predicted values was greater in A and D for FVC in 
both men and women. The observed values for both FVC 
and FEV, were greater in B and C in both men and women. 
For the whole group of 998 non-asthmatic subjects, the 
observed minus Rota et uZ.‘s predicted difference was 
- 34 * 527 ml for FVC and 30 f 455 ml for FEV,. The 
95% confidence interval of the regression line between 
observed and predicted values contained the identity line 
for both FVC and FEV, (Fig. 1). The RSD of the observed 
data (528 ml for FVC and 455 ml for FEV,) in the regres- 
sion analysis indicated in Fig. 1 was higher than the RSD 
shown by the corresponding prediction equations (Table l), 
probably because of the smoking history of the ECRHS’s 
subjects. The latter may account for the fact that the 
percentage of observed ECRHS values below the LLR was 
somewhat higher than the expected theoretical 5%. 
The effects of two factors: (1) cigarette smoking and (2) 
criteria used to define a reference subject by Rota et al., on 
lung function are shown in Table 3). There were 333 
subjects in the ECRHS who were lifetime non-smokers and 
from those only 248 met the screening criteria for health 
status described in detail in (8,16). It is of note that no 
differences in lung function were observed between lifetime 
non-smokers and the subjects who met the inclusion criteria 
of the Barcelona study (8). 
Comparisons between observed lung function (FVC and 
FEV,) in the 998 ECRHS subjects and predicted values 
provided by different authors (C6,8,9), as well as the 
percentage of subjects below the LLR for each author, are 
indicated in Table 4. 
Discussion 
The present study indicates that FVC and FEV, measured 
in 998 non-asthmatic subjects (524 men and 474 women) 
randomly selected from the general population of 2044 
years of age in four Spanish cities participating in the 
ECRHS (Table 3) showed an acceptable fit to Rota et al’s 
prediction equations (8) developed in the early 1980s. Since 
the subjects from the ECRHS were selected because of the 
absence of major respiratory symptoms, we assume that 
they were adequate to examine the clinical validity of our 
reference equations in assessing ventilatory capacity in the 
general population. It should be noted that, by design, the 
analysis was done in a relatively narrow segment of age 
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TABLE 2. Comparison among centres participating in the ECRHS in Spain 
Centre A Centre B Centre C Centre D 
Men 
Number 98 
Age (years) 33 f 7.3 
Height (cm) 174 f 6.2 
Weight (kg) 76 f 9.9 
Current smokers 48 (49%) 
Lifetime non-smokers 30 (31%) 
Mean observed - predicted difference 
FVC (ml) - 84 
FEV, (ml) - 67 
PEF (Is-‘) - 0.6 
Women 
Number 96 
Age (years) 31 f 6.8 
Height (cm) 160 * 6.2 
Weight (kg) 58 f 8.4 
Current smokers 43 (45%) 
Lifetime non-smokers 33 (34%) 
Mean observed - predicted difference 
FVC (ml) - 117 
FEV, (ml) - 50 
PEF (Is-‘) 0.0 
203 113 110 
31 f 7.1 33 zt 8.0 32 h I.6 
172 f 7.0 172 & 6.5 172 & 6.6 
76 * 9.9 77 h 10.3 76 f 10.9 
116 (57%) 74 (65%) 65 (59%) 
60 (30%) 27 (24%) 34 (31%) 
38 - 28 - 134 
110 75 - 12 
- 0.2 0.1 - 0.2 
164 114 100 
31 zt 7.5 33 f 6.9 32 f 7.3 
159 + 6.2 159 f 5.8 158 f 5.3 
63 k 8.4 60 f 10.5 63 f 11.3 
74 (45%) 59 (52%) 51 (51%) 
66 (40%) 43 (38%) 40 (40%) 
13 70 - 139 
54 76 -61 
0.3 0.2 -0.1 
Results expressed as mean 5 standard deviation; PEF, peak expiratory flow. 
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FIG. 1. Plots of the observed values from the ECRHS b-axes) against predicted values (x-axes) for (a) FVC and (b) FEVr 
from the Barcelona study (8). FVC,,,,,,,=0.988 ( f 0.020) x FVC,,,,,,,,+0.022 ( & 0.091), rz0.84. FEVlobserved= 1.022 
( * 0.022) x FEVlpredicted - 0.0526 ( f 0.082), r=0.83. Data within parentheses correspond to the standard error of the 
regression coefficients. 
(from 20 to 44 years) which did not include elderly people. 
However, since linear models are recommended (1 ,l l), the 
age span should only be considered a relatively minor 
limiting factor. 
The effect of tobacco smoking is indicated in Table 3 by 
(1) the magnitude of the difference between observed minus 
predicted values (residuals) and (2) the percentage of sub- 
jects below the LLR, among groups. According to our 
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TABLE 3. Effect of cigarette smoking and screening questionnaire on lung function 
Whole 
ECRHS 
sample 
Current 
smokers 
Non-smokers 
and 
ex-smokers 
Lifetime 
non-smokers 
Reference 
criteria? 
(8) 
Subjects (n) 998 530 
Men 524 303 
Women 474 227 
FEVJFVC (%) 84 + 6.5 82 & 1.8 
Mean observed - predicted difference 
FVC (ml) - 34 f 527* - 65 f 542*** 
FEV, (ml) 30 * 455** - 30 * 477 
Percentage of observed ECRHS values below the LLR$ 
FVC Men 8 11 
Women 7 6 
FEV, Men 7 11 
Women 6 6 
468 333 248 
221 151 122 
247 182 126 
85 f 6.3 85 + 6.2 86 f 6.2 
- 3 i 509 
97 zt 420*** 
- 14 f 493 
100 f 403*** 
4 f 500 
130 f 404*** 
tsubjects from the ECRHS sample who met the criteria established in the reference equations given by Rota et al. (8) to 
define a reference individual. 
SLOW limit of reference: calculated as predicted value - RSD x 1.645. 
Results expressed as mean f standard deviation. 
*P=O.O5, **P=O.O4, ***P<O.Ol; Student’s paired t test between observed and predicted values given by Rota et al. (8). 
TABLE 4. Comparison between observed values from the ECRHS and the predicted values derived from different reference 
equations 
Reference equations 
Rota et al. Paoletti et al. 
(8) (9) 
Crap0 et al. 
(4) 
Knudson et al. 
(6) 
ECSC 
(5) 
FEV,/FVC (%) 82 & 1.8 79 i 1.6 85 f 2.2 85 f 1.8 85 f 1.7 
Mean observed - predicted difference 
FVC (ml) - 34 41527 - 70 zt 526 139 f 527 339 z!c 535 368 f 530 
FEV, (ml) 30 f 455 177 f 452 78 f 453 244 f 458 246 h 449 
Percentage of observed ECRHS values below the LLR* 
FVC Men 8 7 3 3 2 
Women 7 8 3 1 1 
FEV, Men 7 3 5 3 3 
Women 6 3 4 1 1 
*Low limit of reference: calculated as predicted value - RSD x 1.645. 
The RSD values for each author are provided in Table 1. 
Results expressed as mean & standard deviation. 
definition of LLR the expected percentage of healthy non- 
smokers showing lung function values below LLR should 
be 5%. The higher figures (Table 3) observed in the whole 
group of 998 subjects and in the 530 current smokers can be 
attributed to the smoking habit. 
The similar pattern of participation between stage I and 
stage II of the ECRHS in both symptomatic and non- 
asthmatic subjects, described in Methods, does not suggest 
a response bias. One would have expected that a bias 
inducing ‘false asymptomatic’ subjects to participate in the 
study to obtain a medical examination would have pro- 
duced observed values lower than those derived from the 
prediction equations, which was not the case in this study as 
indicated in Table 3. 
The higher FVC and FEV, (Table 2) obtained in centres 
B and C for both men and women compared with measure- 
ments done in centres A and D, despite the use of identical 
equipment and testing procedures, may constitute an 
estimate of the variability due to technicians, since the 
personnel in the former two centres (B and C) were 
experienced in lung function testing before the ECRHS 
began. 
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The ECSC Summary equations (5,ll) showed, similarly 
to the reference equations given by Knudson et al. (6), 
lower predicted values than those provided by the other 
authors analysed in Table 4 and relatively high RSD 
values. Altogether, these two factors account for the low 
percentage of observed values from the ECRHS below the 
corresponding LLR. The behaviour of the ECSC equa- 
tions (5,ll) can be explained because they were derived 
from data collected from a number of different studies, 
essentially carried out before 1980, using different meth- 
ods and from differing populations (5). Paoletti et al’s (9) 
and Rota et d’s (8) reference equations (Table 4) 
showed a similar predicted FVC. However, FEV, pre- 
dicted by Paoletti et al.‘s equations was similar to that 
seen in the ECSC Summary equations. Accordingly, the 
FEViIFVC ratio derived by Paoletti et al. (9) was 
approximately 3% lower than that shown by Rota et al. 
(8) and 5% lower than the actual FEV,/FVC ratio 
obtained for the whole sample of the ECRHS. Observed 
minus predicted differences for FEV, were similar 
between Rota et al. (8) and Crapo et al. (4), but predicted 
FVC in Rota et al. was approximately 100 ml higher than 
in Crap0 et al. 
In summary, the present study seems to validate the 
predicted equations given by Rota et al. (8) for use in the 
clinical assessment of the ventilatory capacity in the 
general Spanish population when comparable methods 
and equipment are used. The results emphasize the need 
for this type of validation, even using a smaller number of 
subjects than in the present study, to select the appropri- 
ate set of reference values for each laboratory (1). 
Although the field of spirometry standardization is still in 
progress (17) one can expect that the generation of 
reference values following standardized procedures will 
greatly facilitate the comparisons among laboratories and 
the development of interpretative strategies for the 
assessment of ventilatory capacity in pulmonary medicine. 
The low predicted values for both FVC and FEV, derived 
from the ECSC Summary equations indicate an urgent 
need to extend this study conducted with the ECRHS 
data from Spain to other populations of European 
origin. 
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